ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Hepatitis C Recurrence after Liver Transplant: A Comparison of Antibody Induction versus No Antibody Induction

S. Patel, J. Jin, E. Benedetti, P. West-Thielke.

University of Illinois Hospital and Health Sciences System, Chicago.

Meeting: 2018 American Transplant Congress

Abstract number: D248

Keywords: Hepatitis C, Induction therapy, Liver transplantation, Recurrence

Session Information

Session Name: Poster Session D: Liver: Viral Hepatitis

Session Type: Poster Session

Date: Tuesday, June 5, 2018

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Background: Hepatitis C virus (HCV) recurrence after orthotopic liver transplant (OLT) is universal and exhibits accelerated progression to cirrhosis. Progression can be mitigated by new direct-acting antivirals (DAA), but barriers to global access are substantial. Thus, strategies to limit recurrence remain necessary. The purpose of this study was to compare the incidence of HCV recurrence in OLT recipients that received antibody (Ab) induction to subjects that were transplanted without Ab induction.

Methods: Patients that underwent an OLT for HCV cirrhosis between 1/1/06 and 3/31/12 were retrospectively identified for analysis. Patients who received induction with a poly- or monoclonal Ab were identified as the Induction group. Patients without poly- or monoclonal Ab induction comprised the No Induction group. The primary outcome is difference in biopsy-proven HCV recurrence at month 3, 6, and 12. Secondary outcome measures included rejection and survival.

Results: 89 patients underwent OLT for HCV cirrhosis during the study period. 18 patients were excluded from analysis, 13 due to combined liver-kidney transplant and 5 due to early loss to follow-up. 23 patients comprised the No Induction group and 48 in the Induction group (Figure 1). A numerically higher incidence of biopsy-proven HCV recurrence was seen in subjects that received poly- or monoclonal Ab induction compared to the No Induction group (Figure 2). At 12 months, 56.3% of patients in the Induction group had HCV recurrence on biopsy versus 34.8% in the No Induction group. Rejection rates remained comparable. Patient survival was similar between groups.

Conclusions: Institution specific results illustrate Ab induction avoidance may be associated with less HCV recurrence after OLT without significantly sacrificing rejection risk and graft function. This strategy can be incorporated into a multi-modal plan to mitigate HCV recurrence post liver transplant.

CITATION INFORMATION: Patel S., Jin J., Benedetti E., West-Thielke P. Hepatitis C Recurrence after Liver Transplant: A Comparison of Antibody Induction versus No Antibody Induction Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Patel S, Jin J, Benedetti E, West-Thielke P. Hepatitis C Recurrence after Liver Transplant: A Comparison of Antibody Induction versus No Antibody Induction [abstract]. https://atcmeetingabstracts.com/abstract/hepatitis-c-recurrence-after-liver-transplant-a-comparison-of-antibody-induction-versus-no-antibody-induction/. Accessed June 6, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences